We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MIP Enters into Agreement with Sanofi-Aventis for Development of a Selective Separation Polymer for Biopharmaceuticals

News   Jan 16, 2009

 
MIP Enters into Agreement with Sanofi-Aventis for Development of a Selective Separation Polymer for Biopharmaceuticals
 
 
 

RELATED ARTICLES

Ancient Enzymes the Catalysts for Discoveries

News

University of Queensland-led research recreating 450 million-year-old enzymes has resulted in a biochemical engineering ‘hack’ which could lead to new drugs, flavours, fragrances and biofuels.

READ MORE

Battery Ventures Acquires TTP Labtech

News

Global investment firm backs growth plans for TTP Labtech, a global leader in liquid handling and sample management.

READ MORE

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

News

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE